Aspirin and pancreatic cancer
This article was originally published in The Tan Sheet
Executive Summary
Researchers estimate "43% of pancreatic cancer cases among nonusers of aspirin might be prevented by aspirin use," according to prospective study appearing in Aug. 7 Journal of the National Cancer Institute. Kristen Anderson, PhD, University of Minnesota, et al., followed 28,283 post-menopausal women from the Iowa Women's Health Study between 1992-1999, identifying 80 cases of pancreatic cancer. Researchers observed "a trend of decreasing risk of pancreatic cancer incidence with increasing frequency of aspirin use per week," finding a 61% reduced risk when aspirin was used at least six times per week. Data "indicate that aspirin might be chemopreventive for pancreatic cancer," Anderson et al. say, although they recommend further studies "with detailed assessments of dose, duration and drug type used"...